Regencell Bioscience Holdings Limited
As of Oct 15, 2026 close
- Market cap
- $4.71B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.51$69.00
- Volume (live)
- -
- Avg. volume (3M)
- 264.74K
Regencell Bioscience Holdings (RGC) Stock Price & Financial Analysis
Regencell Bioscience Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.72 - $11.12 |
|---|---|
| 52-Week High | $69.00 |
| 52-Week Low | $4.51 |
| Open | $7.98 |
| Volume (last close) | 1.92M |
| Average Volume (3M) | 264.74K |
| 50-Day MA | $6.07 |
|---|---|
| 200-Day MA | $18.63 |
| 1-Year Change | −46.96% |
| Market Cap | 4.71B |
|---|---|
| Shares Outstanding | 494.72M |
| Price to Book (P/B) | 352.80 |
| EV/EBITDA | -533.13 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Regencell Bioscience Holdings at a Glance
Regencell Bioscience Holdings (RGC) has a market capitalization of $4.71B.
It holds $14.19M in cash and securities against $544.41K of debt, a net cash position of $13.65M.
Regencell Bioscience Holdings does not currently pay a dividend.
The share price is down 47.0% over the past year. At $9.52 it sits near the bottom of its 52-week range of $4.51 to $69.00, below its 200-day moving average of $18.63.
Frequently Asked Questions About Regencell Bioscience Holdings
What is the current stock price for RGC?
As of the Oct 15, 2026 close, RGC stock trades at $9.52. The 52-week range is $4.51–$69.00, with a day range of $7.72–$11.12.
What is the P/E ratio for RGC?
The P/E ratio (Price-to-Earnings) for RGC is shown in the Key Statistics section. This valuation metric helps compare Regencell Bioscience Holdings Limited to industry peers.
Does RGC pay dividends?
Regencell Bioscience Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RGC?
Analyst ratings and recommendations for RGC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of RGC?
Regencell Bioscience Holdings's market capitalization is $4.71B, classifying it as a mid-cap company. Regencell Bioscience Holdings operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.